Delivery Order SPE2DB20D3103-SPE2DB25FQ3R6
- Not listed
- The Defense Logistics Agency awarded a $17,181.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Ofev 150 mg capsules (60-count). The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of October 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,181.16 to AmerisourceBergen Drug Corp for Ofev 150 mg capsules (60-count units) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026. The place of performance...
- The Defense Logistics Agency awarded a $68,724.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by October 9, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ofev 100 mg capsules (60-count units) with a ceiling value of $17,260.58. This firm fixed-price delivery order, which is expected to be completed by September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Ofev (nintedanib) is a medication...
- The Defense Logistics Agency awarded a $43,151.40 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 100 mg capsules in quantities of 60 units. This is a firm fixed price contract with an ultimate completion date of October 8, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The contract specifies performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units, with a ceiling value of $8,590.58. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract carries an ultimate completion date of August 27, 2025, and performance will be executed from the vendor's corporate office location in...
- The Defense Logistics Agency awarded a $8,590.58 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of OFEV 150 mg capsules (60-unit quantity). The contract, which is non-set-aside and competitively awarded, represents a firm fixed-price delivery order with an ultimate completion date of August 4, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,590.58 to AmerisourceBergen Drug Corp for OFEV (nintedanib) 150 mg capsules (60-count units) on July 18, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order is...
- The Defense Logistics Agency awarded a $51,543.48 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in quantities of 60 units. This is a firm fixed price delivery order with an ultimate completion date of October 2, 2025, and represents a non-competitive set-aside award. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Ofev is a specialty pharmaceutical used primarily in...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3R6Delivery Order
The Defense Logistics Agency awarded a $17,181.16 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev (nintedanib) 150 mg capsules in a quantity of 60 units. This is a firm fixed price, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania location and an ultimate completion date of October 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of competitively awarded delivery orders with DLA covering a broad range of pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies. This particular delivery order for Ofev, a medication used in the treatment of idiopathic pulmonary fibrosis, represents a routine execution of the broader pharmaceutical supply agreement supporting federal military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 9/17/25 |